Inhibitory effects of the herbal medicine Sho-saiko-to (TJ-9) on cell proliferation and procollagen gene expressions in cultured rat hepatic stellate cells

Journal of Hepatology

Volumn 29, Issue 4, 1998, Pages 642-649

  Kayano, Kozo ^a   Sakaida, Isao ^a   Uchida, Koichi ^a   Okita, Kiwamu ^a  

^a YAMAGUCHI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

G0 G1 arrest; Hepatic stellate cell; Herbal medicine; Liver fibrosis; Procollagen mRNA; Sho saiko to (TJ 9)

Indexed keywords

PROCOLLAGEN; PROCOLLAGEN TYPE 3 AMINOPROPEPTIDE; XIAO CHAI HU TANG;

ANIMAL CELL; ARTICLE; CELL CYCLE G0 PHASE; CELL CYCLE G1 PHASE; CELL PROLIFERATION; CELL TRANSFORMATION; FLOW CYTOMETRY; ITO CELL; LIVER CIRRHOSIS; LIVER FIBROSIS; MALE; NONHUMAN; NORTHERN BLOTTING; PRIORITY JOURNAL; RAT; STELLATE CELL;

EID: 0032190943     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0168-8278(98)80161-X     Document Type: Article

References (38)

1. 1. Rojkind M, Giambrone M-A, Biempica L. Collagen types in normal and cirrhotic liver. Gastroenterology 1979; 76: 710-9.
2. 2. Gressner AM, Bachem MG. Cellular sources of noncollagenous matrix proteins: role of fat-storing cells in fibrogenesis. Semin Liver Dis 1990; 10: 30-46.
3. 3. Friedman SL. The cellular basis of hepatic fibrosis. Mechanisms and treatment strategies. N Engl J Med 1993; 328: 1828-35.
4. 4. Sakaida I, Kubota M, Kayano K, Takenaka K, Mori K, Okita K. Prevention of fibrosis reduces enzyme-altered lesions in the rat liver. Carcinogenesis 1994; 15: 2201-6.
5. 5. Sakaida I, Matsumura Y, Akiyama S, Hayashi K, Ishige A, Okita K. Herbal medicine Sho-saiko-to (TJ-9) prevents liver fibrosis and enzyme-altered lesions in rat liver cirrhosis induced by a choline-deficient L-amino acid-defined diet. J Hepatol 1998; 28: 298-306.
6. 6. Ramadori G. The stellate cell (Ito-cell, fat-storing cell, lipocyte, perisinusoidal cell) of the liver. New insights into pathophysiology of an intriguing cell. Virchows Arch B 1991; 61: 147-58.
7. 7. Pinzani M. Novel insights into the biology and physiology of the Ito cell. Pharmacol Ther 1995; 66: 387-412.
8. 8. Friedman SL, Roll FJ, Boyles J, Arenson DM, Bissell DM. Maintenance of differentiated phenotype of cultured rat hepatic lipocytes by basement membrane matrix. J Biol Chem 1989; 264: 10756-62.
9. 9. Geerts A, Lazou JM, Bleser PD, Wisse E. Tissue distribution, quantitation and proliferation kinetics of fat-storing cells in carbon tetrachloride-induced rat liver. Hepatology 1990; 13: 1193-202.
10. 10. Maher JJ, McGuire RF. Extracellular matrix gene expression increases preferentially in rat lipocytes and sinusoidal endothelial cells during hepatic fibrosis in vivo. J Clin Invest 1990; 86: 1641-8.
11. 11. Yamamoto K, Araki N, Ogawa K. Ultrastructural and ultracytochemical examination of the effects of preadministration of Xiao-Chai-Hu-Tang on hepatic disorders induced by D-galactosamine Hcl. Acta Histochem Cytochem 1985; 18: 403-18.
12. 12. Araki N, Noda T, Ogawa K. Cytochemical studies on the effect of intraperitoneal and oral administration of a traditional Chinese medicine (Sho-saiko-to) on the D-galactosamine-induced hepatic injuries of rats. Acta Histochem Cytochem 1988; 21: 439-53.
13. 13. Okita K, Kurokawa N, Yamasaki T, Furukawa T, Li Q, Murakami T, et al. The use of Sho-saiko-to (TJ-9) for chemoprevention of chemical hepatocarcinogenesis in rats and discussion of its possible pharmacologic action. Transgenica 1994; 1: 39-44.
14. 14. Tatsuta M, Ishii H, Baba M, Nakaizumi A, Uehara H. Inhibition by xiao-chai-hu-tang (TJ-9) of development of hepatic foci induced by N-nitrosomorpholine in Sprague-Dawley rats. Jpn J Cancer Res 1991; 82: 987-92.
15. 15. Oka H, Yamamoto S, Kanno T, Kuroki T, Mizoguchi Y, Kobayashi K, et al. Controlled prospective evaluation of Sho-saiko-to in prevention of hepatocellular carcinoma in patients with cirrhosis of the liver. J Med Pharm Soc 1989; 6: 40-4.
16. 16. Oka H, Yamamoto S, Kuroki T, Harihara S, Marumo T, Kim SR, et al. Prospective study of chemoprevention of hepatocellular carcinoma with Sho-saiko-to (TJ-9). Cancer 1995; 76: 743-9.
17. 17. Okita K, Li Q, Murakami T, Takahashi M. Anti-growth effects with components of Sho-saiko-to (TJ-9) on cultured human hepatoma cells. Eur J Cancer Prev 1993; 2: 169-76.
18. 18. Matsuzaki Y, Kurokawa N, Terai S, Matsumura Y, Kobayashi N, Okita K. Cell death induced by baicalein in human hepatocellular carcinoma cell lines. Jpn J Cancer Res 1996; 87: 170-7.
19. 19. Yano H, Mizoguchi A, Fukuda K, Haramaki M, Ogasawara S, Momosaki S, et al. The herbal medicine Sho-saiko-to inhibits proliferation of cancer cell line by inducing apoptosis and arrest at the G0/G1 phase. Cancer Res 1994; 54: 448-54.
20. 20. Kawada N, Kuroki T, Kobayashi K, Inoue M, Kaneda K. Inhibition of myofibroblastic transformation of cultured rat hepatic stellate cells by methylxanthines and dibutyryl cAMR Dig Dis Sci 1996; 41: 1022-9.
21. 21. Chu M-L, Weil D, Wet W, Bernard M, Sippola M, Ramirez F. Isolation of cDNA and genomic clones encoding human proα1 (III) collagen. J Biol Chem 1985; 260: 4357-63.
22. 22. Tso JY, Sun X, Kao T, Reece T, Wu R. Isolation and characterization of rat and human glyceraldehyde-3 phosphate dehydrogenase cDNA: genomic complexity and molecular evolution of the gene. Nucleic Acids Res 1985; 13: 2485-502.
23. 23. Chomczynski P, Sacchi N. Single-step method of RNA isolation by acid guanidium thiocyanate-phenol-chloroform extraction. Anal Biochem 1987; 162: 156-9.
24. 24. Kenneth D B, Ricardo E D, Shankey T V. Clinical Flow Cytometry. Principles and Application. Baltimore: Williams & Wilkins; 1994.
25. 25. Geerts A, Vrijsen R, Rauterberg J, Burt A, Schellinck P, Wisse E. In vitro differentiation of fat-storing cells parallels marked increase of collagen synthesis and secretion. J Hepatol 1989; 9: 59-68.
26. 26. Gressner AM. Time-related distribution profiles of sulfated glycosaminoglycans in cells, cell surface, and media of cultured rat liver fat-storing cells. Soc Exp Biol Med 1991; 196: 307-15.
27. 27. Davis BH, Pratt BM, Madri JA. Retinol and extracellular collagen matrices modulate hepatic Ito cell collagen phenotype and cellular retinol binding protein levels. J Biol Chem 1987; 262: 10280-6.
28. 28. Rockey DC, Maher JJ, Jarnagin WR, Gabbiani G, Friedman SL. Inhibition of rat hepatic lipocyte activation in culture by interferon-γ. Hepatology 1992; 16: 776-84.
29. 29. Seyer JM, Hutcheson ET, Kang AH. Collagen polymorphism in normal and cirrhotic human liver. J Clin Invest 1977; 59: 241-8.
30. 30. Schuppan D. Structure of the extracellular matrix in normal and fibrotic liver: collagen and glycoproteins. Semin Liver Dis 1990; 10: 1-10.
31. 31. Brenner DA, Westwick J, Breindl M. Type I collagen gene regulation and the molecular pathogenesis of cirrhosis. Am J Physiol 1993; 264: G589-95.
32. 32. Wong L, Yamasaki G, Johnson RJ, Friedman SL. Induction of β-platelet-derived growth factor receptor in rat hepatic lipocytes during cellular activation in vivo and in culture. J Clin Invest 1994; 94: 1563-9.
33. 33. Pinzani M, Gesualdo L, Sabbah GM, Abboud HE. Effects of platelet-derived growth factor and other polypeptide mitogens on DNA synthesis and growth of cultured rat liver fat-storing cells. J Clin Invest 1989; 84: 1786-93.
34. 34. Sakaida I, Uchida K, Matsumura Y, Okita K. Interferon gamma treatment prevents procollagen gene expression without affecting TGF-β1 expression in pig serum-induced rat liver fibrosis in vivo. J Hepatol 1998; 28: 471-9.
35. 35. Sakaida I, Matsumura Y, Kubota M, Kayano K, Takenaka K, Okita K. The prolyl 4-hydroxylase inhibitor HOE 077 prevents activation of Ito cells, reducing procollagen gene expression in rat liver fibrosis induced by choline deficient L-amino acid-defined diet. Hepatology 1996; 23: 755-63.
36. 36. Matsumura Y, Sakaida I, Uchida K, Kimura T, Ishihara T, Okita K. Prolyl 4-hydroxylase inhibitor (HOE 077) inhibits pig serum-induced rat liver fibrosis by preventing stellate cell activation. J Hepatol 1997; 27: 185-92.
37. 37. Davis BH, Kramer RT, Davidson NO. Retinoic acid modulates rat Ito cell proliferation, collagen and transforming growth factor β production. J Clin Invest 1990; 86: 2062-70.
38. 38. Matsuda Y, Matsumoto K, Yamada A, Ichida T, Asakura H, Komoriya Y, et al. Preventive and therapeutic effects in rats of hepatocyte growth factor infusion on liver fibrosis/ cirrhosis. Hepatology 1997; 26: 81-9.